Fundraising FoxLabyRx
1 known investors
Find your way into LabyRx
Sign up to find every way you can get introduced to LabyRx
- Your email: who you already know at LabyRx, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the LabyRx team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
LabyRx develops therapeutic cancer vaccines based on Labyrinthin, a protein target found on adenocarcinoma cells, using synthetic peptide immunotherapy to train the immune system to attack tumors. The company, an immuno-oncology biotech, also pursues monoclonal antibody drug development and combination treatments for patients with adenocarcinomas.
Investors · 1
Frequently asked questions
- What does LabyRx do?
- LabyRx develops therapeutic cancer vaccines based on Labyrinthin, a protein target found on adenocarcinoma cells, using synthetic peptide immunotherapy to train the immune system to attack tumors. The company, an immuno-oncology biotech, also pursues monoclonal antibody drug development and combination treatments for patients with adenocarcinomas.
- Who are LabyRx's investors?
- LabyRx's investors include Red Sails Investment.